Nextcell Pharma | BioStock Life Science Summit 2020

23 November 2020 - 22:00
Nextcell Pharma company presentation and Q&A at the BioStock Life Science Summit 2020....
Nasdaq First North GM Stockholm (Sweden)
NextCell Pharma AB
NextCell Pharma is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More